Sarepta Therapeutics (SRPT) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -18.3 | 526.1 | -15.2 | -31.9 | -15.1 | -11.4 | |||
Changes by years, y/y, % | +15% | -2 975% | -103% | +110% | -52% | -1.0% |
Sarepta Therapeutics. P/FCF
Sarepta Therapeutics. P/FCF, changes, %
Sarepta Therapeutics (SRPT) P/FCF US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
P/FCF | -26.0 | -19.1 | -17.5 | -15.3 | -18.9 | -11.4 | ||
Changes by years, y/y, % | +47% | +1% | -48% | -52% | -27% | |||
Changes by quarters, q/q, % | -19% | -26% | -8% | -12% | +23% |